Gene-environment interactions between HPA axis regulatory genes and stressful life events in suicide attempts by Ben-Efraim, Yair Jacob
 The National Centre for Suicide Research and Prevention of 
Mental Ill-health (NASP) at the Department of Learning, 
Informatics, Management, and Ethics (LIME) 
Gene-environment interactions between 
HPA axis regulatory genes and stressful 
life events in suicide attempts 
 
ACADEMIC DISSERTATION 
For the degree of PhD at Karolinska Institutet 
The thesis will be defended in public at the Swedish Society of 
Medicine, Klara Östra Kyrkogata 10, Stockholm 
 
At 13:00 on Monday, November 19, 2012 
 
by 
 
Yair Jacob Ben-Efraim 
M.Sc. 
Stockholm 2012 
Opponent:  
Professor J. John Mann  
New York State Psychiatric Institute 
Columbia University  
Department of Psychiatry  
 
Examination board:  
Professor Per-Anders Rydelius  
Karolinska Institutet  
Department of Women's and Children's 
Health 
 
Professor Martin Schalling  
Karolinska Institutet  
Department of Molecular Medicine and 
Surgery  
 
Professor Lars Oreland  
Uppsala University  
Department of Neuroscience, 
Pharmacology 
Main Supervisor:  
Associate Professor Marcus Sokolowski  
Karolinska Institutet  
NASP, LIME 
 
Co-supervisor:  
Professor Danuta Wasserman  
Karolinska Institutet  
NASP, LIME 
  
Abstract       ISBN 978-91-7457-943-7 
Suicide is a leading cause of death. In the future, treatment for suicidal behavior, as 
well as public health prevention and/or intervention efforts, may be guided by genetic 
epidemiology. This research is informed by biological alterations which have been 
previously observed in suicidal behavior. Such alterations include dysregulation of the 
cortisol response to psychosocial stress, which is in large part mediated by the 
hypothalamic-pituitary-adrenal (HPA) axis. HPA axis functioning is influenced e.g. by 
heritable variation in regulatory genes, by exposure to stressful life events (SLEs), 
and/or by gene-environment interactions (G x Es) of regulatory genetic variants with 
SLEs. Using a family-based design of proband offspring who have made a suicide 
attempt (SA) and their parents, we tested and characterized associations of 
transmitted variants in candidate genes that regulate HPA axis activation, as well as 
G x Es of these variants with SLEs, with SA and secondary outcomes. 
 In Study 1, we showed a G x E between a variant in corticotropin releasing 
hormone receptor type-1 (CRHR1), a gene which has a major role in mediating HPA 
axis activation, and physical assault in childhood/adolescence. We further observed a 
novel and independent G x E between another unlinked variant and physical assault 
in adulthood. These findings confirmed and extended previous findings on adulthood 
depressive symptoms, cortisol response, and alcohol misuse by other groups.  
 In Study 2, we investigated 98% of currently known common single nucleotide 
polymorphisms (SNPs) and certain low-frequency SNPs in serotonin receptor type-2a 
(HTR2A), a gene involved in serotonergic system modulation of HPA axis activation, 
and showed novel genetic linkage/association of a promoter SNP and a low frequency 
exon 2 SNP, as well as a novel G x E between a well-studied exon 1 SNP and exposure 
to cumulative lifetime SLEs. We further characterized this G x E, revealing a complex 
parent-of-origin effect in females, which may partly explain inconsistent findings in the 
literature.  
 In study 3, we investigated twenty-four genes in the glutamatergic, γ-
aminobutyric acid (GABA)-ergic, and polyaminergic systems that are known to link 
several brain areas involved in emotional processing with HPA axis activation. We 
showed linkage/association of 3 SNPs in an N-methyl-D-aspartate (NMDA) receptor 
subunit type-2B gene (GRIN2B), and 2 SNPs and 1 haplotype in a gene which codes for 
a rate limiting enzyme in polyamine biosynthesis (ODC1). A G x E was also observed 
between another ODC1 SNP and physical assault in childhood/adolescence. 
 In study 4, we investigated 100% of currently known common SNPs and a low 
frequency SNP in arginine vasopressin receptor type-1B (AVPR1B), a gene involved 
with CRHR1 in partially overlapping roles in HPA axis activation. We showed 
linkage/association of two SNPs and a corresponding major allele haplotype across the 
gene predominantly on current depressive symptoms in SA. Interestingly, we found no 
evidence of a G x E between AVPR1B variants and SLEs, or any gene-gene interaction 
effects with CRHR1 variants.  
 In all studies, the findings were complemented with case-control re-analysis of 
SA offspring with healthy volunteers; characterized with SA-concomitant outcomes, as 
well as lifetime psychiatric diagnoses, and/or other descriptive variables; and discussed 
with regard to previous findings by our group or others, and to potential mechanistic 
roles. These findings support a stress-diathesis model of suicidal behavior, and a 
potential etiological role in the suicidal process for novel genetic variants and variants 
that have previously associated with stress-related HPA axis dysregulation, 
maladaptive behaviors and neuropsychiatric outcomes. The strength of these results is 
supported by the family-based design, which is robust to population substructure, and 
relatively comprehensive investigations of genetic variation, signaling pathway, and/or 
G x E. Further investigation and consistent replication across samples are warranted 
before utility in clinical diagnosis, treatment and/or public health efforts. 
